168 related articles for article (PubMed ID: 19042971)
1. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response.
Koeppel M; van Heeringen SJ; Smeenk L; Navis AC; Janssen-Megens EM; Lohrum M
Nucleic Acids Res; 2009 Feb; 37(2):322-35. PubMed ID: 19042971
[TBL] [Abstract][Full Text] [Related]
2. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
3. p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1.
Matsuzawa S; Takayama S; Froesch BA; Zapata JM; Reed JC
EMBO J; 1998 May; 17(10):2736-47. PubMed ID: 9582267
[TBL] [Abstract][Full Text] [Related]
4. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
5. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.
Goudarzi KM; Nistér M; Lindström MS
Cancer Biol Ther; 2014; 15(11):1499-514. PubMed ID: 25482947
[TBL] [Abstract][Full Text] [Related]
6. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
[TBL] [Abstract][Full Text] [Related]
7. Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.
Liu L; Chen X; Xie S; Zhang C; Qiu Z; Zhu F
Hepatology; 2012 Nov; 56(5):1760-9. PubMed ID: 22576474
[TBL] [Abstract][Full Text] [Related]
8. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.
Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A
Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
[TBL] [Abstract][Full Text] [Related]
10. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D.
Krześniak M; Zajkowicz A; Matuszczyk I; Rusin M
Mech Ageing Dev; 2014 Jul; 139():11-21. PubMed ID: 24915467
[TBL] [Abstract][Full Text] [Related]
12. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.
Giono LE; Manfredi JJ
Mol Cell Biol; 2007 Jun; 27(11):4166-78. PubMed ID: 17371838
[TBL] [Abstract][Full Text] [Related]
13. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53.
Taha TA; Osta W; Kozhaya L; Bielawski J; Johnson KR; Gillanders WE; Dbaibo GS; Hannun YA; Obeid LM
J Biol Chem; 2004 May; 279(19):20546-54. PubMed ID: 14988393
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis.
Thompson T; Tovar C; Yang H; Carvajal D; Vu BT; Xu Q; Wahl GM; Heimbrook DC; Vassilev LT
J Biol Chem; 2004 Dec; 279(51):53015-22. PubMed ID: 15471885
[TBL] [Abstract][Full Text] [Related]
16. Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2.
Gresko E; Roscic A; Ritterhoff S; Vichalkovski A; del Sal G; Schmitz ML
EMBO J; 2006 May; 25(9):1883-94. PubMed ID: 16601678
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Wip-1 phosphatase expression in MCF-7 breast cancer cells enhances doxorubicin-induced apoptosis through p53-mediated transcriptional activation of Bax.
Kong W; Jiang X; Mercer WE
Cancer Biol Ther; 2009 Mar; 8(6):555-63. PubMed ID: 19242108
[TBL] [Abstract][Full Text] [Related]
18. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis.
Nelson V; Davis GE; Maxwell SA
Apoptosis; 2001 Jun; 6(3):221-34. PubMed ID: 11388671
[TBL] [Abstract][Full Text] [Related]
19. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
20. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
